What is Sernova Corp.?

Sernova Corp. is a clinical-stage regenerative medicine company focusing on therapeutic devices for chronic diseases like diabetes and thyroid disorders.

When is Sernova's earnings release?

Sernova Corp. will announce its earnings on December 22, 2025, post-market close on the Toronto Stock Exchange (TSX). See SVA.TO for more.

What is the current price of Sernova stock?

As of this report, Sernova's stock is priced at CAD 0.13, with a market capitalization of approximately CAD 42.7 million on the TSX in Canada. Stock prices can fluctuate based on market conditions.

What are analysts predicting for Sernova's stock?

Analysts, as per Meyka AI, suggest a 'SELL' rating with a C+ grade based on financial metrics and sector performance comparisons. The forecast projects a slight potential upside.

How does Sernova compare within the biotechnology sector?

Sernova has faced challenges similar to other biotechnology firms, marked by revenue losses and competition. However, its focus on innovation in regenerative medicine provides a niche advantage.

CA Stocks

Sernova Corp. Before Open (21 Dec 2025): Awaiting Earnings Impact

ByHuzaifa Zahoor December 21, 2025December 21, 2025

With its earnings announcement just around the corner, Sernova Corp. (TSX: SVA) is under the microscope. The company’s upcoming report is highly anticipated by investors eager to gauge its performance and future outlook.